Article Details

Gritstone Oncology (NASDAQ:GRTS) Stock Rating Lowered by Zacks Investment Research

Retrieved on: 2020-07-13 20:21:33

Tags for this article:

Click the tags to see associated articles and topics

Gritstone Oncology (NASDAQ:GRTS) Stock Rating Lowered by Zacks Investment Research. View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP now owns 22,548 shares of the company's stock valued at $131,000 after buying an additional 6,798 shares during the last ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up